Actavis officially changes name to Allergan

Actavis has completed the change of its company name to Allergan, following the approval of the rebranding by the firm's shareholders earlier this year.

The name change follows the Actavis acquisition of Allergan in March 2015, a move that created one of the world's top ten pharmaceutical companies by revenue.

A rebranding campaign has been kicked off to guide the transition of the company's facilities, operations and commercial presence around the world to the new name, though the US and Canadian generics business will retain the Actavis identity.

Additionally, the organisation has launched a new corporate website and introduced a refreshed version of its logo to mark the changeover.

Brent Saunders, chief executive officer and president of Allergan, said: "By adopting the Allergan name, we are ensuring that our corporate identity reflects the transformation of our company within the pharmaceutical industry and our position as a dynamic new breed of company – a leader in Growth Pharma."

The company has made a number of key acquisitions in the last year in addition to the Allergan deal, including the purchases of Auden McKenzie and Forest Laboratories.